NDRA MEXC RealStocks
Own real NDRA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:14:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ENDRA Life Sciences Inc. (NDRA) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3.99, with a market capitalization of $6.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.96 to $6.80. This page covers its latest market performance, valuation, price trends and company information.
$6.63M | |
$4.05 | |
$4.12 | |
$3.62 | |
$3.92 | |
14.04K | |
29.51K | |
-- | |
$6.80 | |
$2.96 | |
-- | |
2026-06-30 |
ENDRA Life Sciences Inc. (NDRA) last closed at $3.99 as of 2026-11-19 00:31:00, down 3.83% ($0.15) from the previous close of $3.92.
During the latest regular trading session, NDRA traded between $3.62 and $4.12, with a volume of 14.04K shares. The closing price was near the upper end and near the lower end of its 52-week range.
NDRA is unchanged as of the last close.
Over the past seven days, ENDRA Life Sciences Inc. (NDRA) moved from $4.84 to $3.99, representing a decline of 17.67% ($0.86).
The stock traded between $3.44 and $5.14 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 7.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 26.7%
NDRA is currently trading at $3.99, placing it 26.7% of the way from its 52-week low of $2.96 to its 52-week high of $6.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ENDRA Life Sciences Inc. (NDRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NDRA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NDRA shares and USD.
NDRA Shares to USD
1.00 NDRA shares = 3.985 USD
Calculations are estimates based on the latest available price and are for reference only.